Absorption, distribution, metabolism and excretion of darolutamide (a novel non-steroidal androgen receptor antagonist) in rats. 2020

Päivi Taavitsainen, and Hille Gieschen, and Timo Korjamo, and Marja Kähkönen, and Chira Malmström, and Olaf Prien, and Michael Niehues, and Steffen Sandmann, and Wiebke Janssen, and Mikko Koskinen
Orion Corporation Orion Pharma, Turku, Finland.

1. Darolutamide is a novel selective androgen receptor antagonist consisting of two pharmacologically equipotent diastereoisomers. The absorption, distribution, metabolism and excretion properties of darolutamide in rats are reported.2. Non- or [14C]-labelled darolutamide, its diastereoisomers and major metabolite were studied in intact and bile duct-cannulated rats (oral and intravenous administration), and rat hepatocytes.3. Darolutamide was quickly (1 h to reach maximum plasma concentration) and completely absorbed after oral administration. Absolute bioavailability was high. Keto-darolutamide was the most abundant metabolite in rat hepatocytes and the only major one in plasma. Interconversion between diastereoisomers was observed.4. After oral administration, radioactivity distributed widely and homogeneously. Penetration into brain was low (brain/blood ratio = 0.079). Elimination was rapid from most tissues. Excretion occurred rapidly, and routes were similar irrespective of administration routes. Complete mass balance was reached by 168 h post-dose. Most radioactivity (61-64%) was excreted in faeces, while relevant amounts (30-33%) were also excreted into urine. The main clearance routes were metabolism via oxidative reactions and glucuronidation. After intravenous administration, a relevant extent of the dose (20%) underwent extrabiliary excretion as darolutamide.

UI MeSH Term Description Entries
D007408 Intestinal Absorption Uptake of substances through the lining of the INTESTINES. Absorption, Intestinal
D011720 Pyrazoles Azoles of two nitrogens at the 1,2 positions, next to each other, in contrast with IMIDAZOLES in which they are at the 1,3 positions.
D001826 Body Fluids Liquid components of living organisms. Body Fluid,Fluid, Body,Fluids, Body
D005243 Feces Excrement from the INTESTINES, containing unabsorbed solids, waste products, secretions, and BACTERIA of the DIGESTIVE SYSTEM.
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001646 Bile An emulsifying agent produced in the LIVER and secreted into the DUODENUM. Its composition includes BILE ACIDS AND SALTS; CHOLESTEROL; and ELECTROLYTES. It aids DIGESTION of fats in the duodenum. Biliary Sludge,Sludge, Biliary
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities
D014018 Tissue Distribution Accumulation of a drug or chemical substance in various organs (including those not relevant to its pharmacologic or therapeutic action). This distribution depends on the blood flow or perfusion rate of the organ, the ability of the drug to penetrate organ membranes, tissue specificity, protein binding. The distribution is usually expressed as tissue to plasma ratios. Distribution, Tissue,Distributions, Tissue,Tissue Distributions
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

Päivi Taavitsainen, and Hille Gieschen, and Timo Korjamo, and Marja Kähkönen, and Chira Malmström, and Olaf Prien, and Michael Niehues, and Steffen Sandmann, and Wiebke Janssen, and Mikko Koskinen
August 2017, European journal of drug metabolism and pharmacokinetics,
Päivi Taavitsainen, and Hille Gieschen, and Timo Korjamo, and Marja Kähkönen, and Chira Malmström, and Olaf Prien, and Michael Niehues, and Steffen Sandmann, and Wiebke Janssen, and Mikko Koskinen
September 2012, Xenobiotica; the fate of foreign compounds in biological systems,
Päivi Taavitsainen, and Hille Gieschen, and Timo Korjamo, and Marja Kähkönen, and Chira Malmström, and Olaf Prien, and Michael Niehues, and Steffen Sandmann, and Wiebke Janssen, and Mikko Koskinen
January 2021, Current drug metabolism,
Päivi Taavitsainen, and Hille Gieschen, and Timo Korjamo, and Marja Kähkönen, and Chira Malmström, and Olaf Prien, and Michael Niehues, and Steffen Sandmann, and Wiebke Janssen, and Mikko Koskinen
October 2018, Clinical genitourinary cancer,
Päivi Taavitsainen, and Hille Gieschen, and Timo Korjamo, and Marja Kähkönen, and Chira Malmström, and Olaf Prien, and Michael Niehues, and Steffen Sandmann, and Wiebke Janssen, and Mikko Koskinen
September 2004, Biopharmaceutics & drug disposition,
Päivi Taavitsainen, and Hille Gieschen, and Timo Korjamo, and Marja Kähkönen, and Chira Malmström, and Olaf Prien, and Michael Niehues, and Steffen Sandmann, and Wiebke Janssen, and Mikko Koskinen
July 2012, Xenobiotica; the fate of foreign compounds in biological systems,
Päivi Taavitsainen, and Hille Gieschen, and Timo Korjamo, and Marja Kähkönen, and Chira Malmström, and Olaf Prien, and Michael Niehues, and Steffen Sandmann, and Wiebke Janssen, and Mikko Koskinen
January 2010, Biochemical and biophysical research communications,
Päivi Taavitsainen, and Hille Gieschen, and Timo Korjamo, and Marja Kähkönen, and Chira Malmström, and Olaf Prien, and Michael Niehues, and Steffen Sandmann, and Wiebke Janssen, and Mikko Koskinen
October 2019, Der Urologe. Ausg. A,
Päivi Taavitsainen, and Hille Gieschen, and Timo Korjamo, and Marja Kähkönen, and Chira Malmström, and Olaf Prien, and Michael Niehues, and Steffen Sandmann, and Wiebke Janssen, and Mikko Koskinen
May 1979, Chemical & pharmaceutical bulletin,
Päivi Taavitsainen, and Hille Gieschen, and Timo Korjamo, and Marja Kähkönen, and Chira Malmström, and Olaf Prien, and Michael Niehues, and Steffen Sandmann, and Wiebke Janssen, and Mikko Koskinen
December 2017, Xenobiotica; the fate of foreign compounds in biological systems,
Copied contents to your clipboard!